Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298805 · ClinicalTrials.gov registry record
A Quality of Life Study in Patients With Migraines
A clinical trial, sponsored by Northwell Health.
- Terminated
- Registry status
- 52
- Enrollment target
NCT00298805: Clinical Trial study, sponsored by Northwell Health.
NCT00298805 is a clinical trial that was terminated before completion, run by Northwell Health. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00298805 was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-01 |
| Est. Completion | 2013-04 |
Why NCT00298805 stopped before completion
NCT00298805 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00298805 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00298805 about?
NCT00298805 is a clinical study titled "A Quality of Life Study in Patients With Migraines". The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.
What is the current status of trial NCT00298805?
This trial is currently terminated. The enrollment target is 52 participants. The study started on 2006-01. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT00298805?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia